|Lever's histopathology of the skin|
R Elenitsas, GF Murphy, BL Johnson, X Xu
Wolters Kluwer, 2009
|Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma|
G Bollag, P Hirth, J Tsai, J Zhang, PN Ibrahim, H Cho, W Spevak, C Zhang, ...
Nature 467 (7315), 596-599, 2010
|A tumorigenic subpopulation with stem cell properties in melanomas|
D Fang, TK Nguyen, K Leishear, R Finko, AN Kulp, S Hotz, PA Van Belle, ...
Cancer research 65 (20), 9328-9337, 2005
|Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer|
C Twyman-Saint Victor, AJ Rech, A Maity, R Rengan, KE Pauken, ...
Nature 520 (7547), 373-377, 2015
|Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K|
J Villanueva, A Vultur, JT Lee, R Somasundaram, M Fukunaga-Kalabis, ...
Cancer cell 18 (6), 683-695, 2010
|Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification|
J Guo, L Si, Y Kong, KT Flaherty, X Xu, Y Zhu, CL Corless, L Li, H Li, ...
Journal of clinical oncology 29 (21), 2904-2909, 2011
|T-cell invigoration to tumour burden ratio associated with anti-PD-1 response|
AC Huang, MA Postow, RJ Orlowski, R Mick, B Bengsch, S Manne, W Xu, ...
Nature 545 (7652), 60-65, 2017
|Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response|
G Chen, AC Huang, W Zhang, G Zhang, M Wu, W Xu, Z Yu, J Yang, ...
Nature 560 (7718), 382-386, 2018
|Isolation of a novel population of multipotent adult stem cells from human hair follicles|
H Yu, D Fang, SM Kumar, L Li, TK Nguyen, G Acs, M Herlyn, X Xu
The American journal of pathology 168 (6), 1879-1888, 2006
|Benign pigmented lesions and malignant melanoma|
D Elder, R Elenitsas, GF Murphy, X Xu
Lever's histopathology of the skin 9, 742-73, 1997
|Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation|
SM Kumar, S Liu, H Lu, H Zhang, PJ Zhang, PA Gimotty, M Guerra, W Guo, ...
Oncogene 31 (47), 4898-4911, 2012
|Targeting ER stress–induced autophagy overcomes BRAF inhibitor resistance in melanoma|
XH Ma, SF Piao, S Dey, Q Mcafee, G Karakousis, J Villanueva, LS Hart, ...
The Journal of clinical investigation 124 (3), 1406-1417, 2014
|Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix|
Z Gombos, X Xu, CS Chu, PJ Zhang, G Acs
Clinical Cancer Research 11 (23), 8364-8371, 2005
|Large-scale analysis of KIT aberrations in Chinese patients with melanoma|
Y Kong, L Si, Y Zhu, X Xu, CL Corless, KT Flaherty, L Li, H Li, X Sheng, ...
Clinical Cancer Research 17 (7), 1684-1691, 2011
|Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues|
MT Tetzlaff, A Liu, X Xu, SR Master, DA Baldwin, JW Tobias, VA Livolsi, ...
Endocrine pathology 18 (3), 163-173, 2007
|Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging|
PA Gimotty, DP Guerry, ME Ming, R Elenitsas, X Xu, B Czerniecki, F Spitz, ...
Journal of clinical oncology 22 (18), 3668-3676, 2004
|Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients|
T Condamine, GA Dominguez, JI Youn, AV Kossenkov, S Mony, ...
Science immunology 1 (2), 2016
|Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system|
A Jambusaria-Pahlajani, PA Kanetsky, PS Karia, WT Hwang, JM Gelfand, ...
JAMA dermatology 149 (4), 402-410, 2013
|Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3|
EV Abel, KJ Basile, CH Kugel, AK Witkiewicz, K Le, RK Amaravadi, ...
The Journal of clinical investigation 123 (5), 2155-2168, 2013
|Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort|
L Si, Y Kong, X Xu, KT Flaherty, X Sheng, C Cui, Z Chi, S Li, L Mao, J Guo
European journal of cancer 48 (1), 94-100, 2012